Stocklytics Platform
Asset logo for symbol MD
MEDNAX
MD62
$14.49arrow_drop_down0.75%-$0.10
Asset logo for symbol MD
MD62

$14.49

arrow_drop_down0.75%

Performance History

Chart placeholder
Key Stats
Open$14.83
Prev. Close$14.76
EPS-2.24
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range14.10
14.81
52 Week Range6.62
16.62
Ratios
Revenue-
EPS-2.24

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About MEDNAX (MD)

MEDNAX Inc (MD) is a healthcare solutions partner that provides a suite of physician services including neonatology, anesthesiology, maternal-fetal medicine, pediatric cardiology, and other pediatric specialty services. With a strong focus on quality patient care, MEDNAX operates in hospitals and other healthcare facilities across the United States. The company is committed to delivering innovative and cost-effective solutions that meet the evolving needs of its patients and healthcare partners.
As of the latest available stock price history, MEDNAX Inc (MD) has experienced fluctuations in its stock price over the years. Investors can track the historical performance of the stock to gain insights into its market trends and potential opportunities for growth. MEDNAX Inc (MD) aims to provide investors with timely and accurate financial information to facilitate informed decision-making.
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. James D. Swift M.D.
Headquarters
Sunrise
Employees
5250
Exchange
NYSE
add MEDNAX  to watchlist

Keep an eye on MEDNAX

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is MEDNAX 's (MD) price per share?

The current price per share for MEDNAX (MD) is $14.49. The stock has seen a price change of -$0.11 recently, indicating a -0.75% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for MEDNAX (MD)?

For MEDNAX (MD), the 52-week high is $16.62, which is 14.73% from the current price. The 52-week low is $6.62, the current price is 118.88% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is MEDNAX (MD) a growth stock?

MEDNAX (MD) has shown an average price growth of -7.34% over the past three years. It has received a score of 37 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying MEDNAX as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is MEDNAX (MD) stock price performance year to date (YTD)?

As of the latest data, MEDNAX (MD) has a year-to-date price change of 54.48%. Over the past month, the stock has experienced a price change of 13.83%. Over the last three months, the change has been 34.79%. Over the past six months, the figure is 94.24%. Looking at a longer horizon, the five-year price change stands at -45.44%.
help

Is MEDNAX (MD) a profitable company?

MEDNAX (MD) has a net income of -$60.41M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 21.13% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 10.26% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 1.15%, providing insight into the company's sales performance and growth. The gross profit is $421.56M. Operating income is noted at $7.32M. Furthermore, the EBITDA is $200.94M.
help

What is the market capitalization of MEDNAX (MD)?

MEDNAX (MD) has a market capitalization of $1.24B. The average daily trading volume is 14.48, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level